Esperion Therapeutics Inc.’s filing revealed that its President and CEO Koenig Sheldon L. unloaded Company’s shares for reported $26132.0 on Sep 17 ’24. In the deal valued at $1.80 per share,14,550 shares were sold. As a result of this transaction, Koenig Sheldon L. now holds 752,266 shares worth roughly $-1.57 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Warren Eric sold 2,608 shares, generating $4,650 in total proceeds. Upon selling the shares at $1.78, the Chief Commercial Officer now owns 162,659 shares.
Before that, Foody Joanne M. bought 3,381 shares. Esperion Therapeutics Inc. shares valued at $6,015 were divested by the Officer at a price of $1.78 per share.
BofA Securities downgraded its Esperion Therapeutics Inc. [ESPR] rating to an Underperform from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early January from “a Buy” to “a Neutral”. Northland Capital revised its rating on August 01, 2023. It rated ESPR as “a Market perform” which previously was an “an Under perform”.
Price Performance Review of ESPR
On Monday, Esperion Therapeutics Inc. [NASDAQ:ESPR] saw its stock jump 6.09% to $2.09. Over the last five days, the stock has gained 2.45%. Esperion Therapeutics Inc. shares have fallen nearly -30.10% since the year began. Nevertheless, the stocks have risen 166.34% over the past one year. While a 52-week high of $3.40 was reached on 04/08/24, a 52-week low of $0.70 was recorded on 10/02/24. SMA at 50 days reached $1.8200, while 200 days put it at $2.2600.
Levels Of Support And Resistance For ESPR Stock
The 24-hour chart illustrates a support level at 1.9900, which if violated will result in even more drops to 1.8800. On the upside, there is a resistance level at 2.1500. A further resistance level may holdings at 2.2000. The Relative Strength Index (RSI) on the 14-day chart is 60.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1200, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 16.35%. Stochastics %K at 66.15% indicates the stock is a holding.
How much short interest is there in Esperion Therapeutics Inc.?
A steep rise in short interest was recorded in Esperion Therapeutics Inc. stocks on 2024-09-30, dropping by -2.97 million shares to a total of 37.47 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 40.44 million shares. There was a decline of -7.93%, which implies that there is a negative sentiment for the stock.
